Dr. Regan with Stock News Now

by LexaGene | Nov 18, 2021 | Investor Information

Home » Investor Information » Dr. Regan with Stock News Now

Dr. Jack Regan discusses scaling MiQLab production and preparing for SNN Network’s Summer Virtual Event, the premier event in MicroCap Finance, with Stock News Now’s CEO Robert Kraft.

Hear the latest on what’s happening with LexaGene as it prepares for its conferences and tradeshow exhibitions.

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Subscribe for Updates